talazoparib,enzalutamide
pfizer,astellas
['crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'enzalu', 'enzalutamide']
important findings from showing the benefit of adding #talozoparib to #enzalutamide in first line #mcrpc. 37% reduced risk of #progression or #death. 30% reduced risk in #hrr negative. results similar across subgroups. #gu23 
Editor Emeritus of @pcan_journal; Dir of CIRCL, studying effects of lifestyle choices on cancer risk and progression; AD Education/Training @CSCancerCare.